CSPC Pharmaceutical Group Limited (HKG:1093)
Hong Kong · Delayed Price · Currency is HKD 9.71
+0.09 (0.94%)
Apr 2, 2026, 4:08 PM HKT
CSPC Pharmaceutical Group Market Cap
CSPC Pharmaceutical Group has a market cap or net worth of 111.01 billion as of April 2, 2026. Its market cap has increased by 102.75% in one year.
Market Cap
111.01B
Enterprise Value
103.39B
Revenue
28.94B
Ranking
n/a
PE Ratio
25.68
Stock Price
9.71
Market Cap Chart
Since December 4, 1995, CSPC Pharmaceutical Group's market cap has increased from 696.00M to 111.01B, an increase of 15,850.42%. That is a compound annual growth rate of 18.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 111.01B | 15.18% |
| Dec 31, 2025 | 96.38B | 74.70% |
| Dec 31, 2024 | 55.17B | -35.87% |
| Dec 29, 2023 | 86.02B | -11.96% |
| Dec 30, 2022 | 97.71B | -3.19% |
| Dec 31, 2021 | 100.93B | 6.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 270.08B |
| Hansoh Pharmaceutical Group Company | 238.28B |
| Innovent Biologics | 158.77B |
| JD Health International | 157.20B |
| WuXi Biologics | 144.73B |
| Akeso | 129.42B |
| Sichuan Kelun-Biotech Biopharmaceutical | 117.41B |
| Sino Biopharmaceutical | 113.10B |